Gene Expression Profile of Leiomyoma and Myometrium and the Effect of Gonadotropin Releasing Hormone Analogue Therapy

[1] Brandon DD(1993)Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas Am J Obstet Gynecol 169 78-85

[2] Bethea CL(1995)Estrogen receptor gene expression in human uterine leiomyomata J Clin Endocrinol Metab 80 1876-1881

[3] Strawn EY(1998)Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma Tumour Biol 19 126-131

[4] Brandon DD(1993)Treatment of uterine myomas with GnRH agonists Semin Reprod Endocrinol 11 154-161

[5] Erickson TE(1993)Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist Fertil Steril 60 642-646

[6] Keenan EJ(2000)A prospective randomized study comparing endocrinological and clinicaleffects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis J Obstet Gynaecol Res 26 325-331

[7] Fujimoto J(1993)An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: A prospective, randomized, double blind, placebo-controlled, crossover trial J Clin Endocrinol Metab 76 1217-1223

[8] Hirose R(1996)Gonadotropin releasing hormone (GnRH) and GnRH receptor gene expression in human myometrial and leiomyomta and the direct action of GnRH analogs on myometrial smooth muscle cells interaction with ovarian steroids in vitro J Clin Endocrinol Metab 81 3215-3221

[9] Ichigo S(1999)Matrix metalloproteinases and tissue inhibitor of MMPs (TIMPs): Expression in human myometrial smooth muscle cell and regulation by transforming growth factor β1 Mol Hum Reprod 5 950-954

[10] Sakaguchi H(1999)Regulation of transforming growth factor-β1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells J Clin Endocrinol Metab 84 4138-4143

[1] Brandon DD(1993)Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas Am J Obstet Gynecol 169 78-85

[2] Bethea CL(1995)Estrogen receptor gene expression in human uterine leiomyomata J Clin Endocrinol Metab 80 1876-1881

[3] Strawn EY(1998)Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma Tumour Biol 19 126-131

[4] Brandon DD(1993)Treatment of uterine myomas with GnRH agonists Semin Reprod Endocrinol 11 154-161

[5] Erickson TE(1993)Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist Fertil Steril 60 642-646

[6] Keenan EJ(2000)A prospective randomized study comparing endocrinological and clinicaleffects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis J Obstet Gynaecol Res 26 325-331

[7] Fujimoto J(1993)An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: A prospective, randomized, double blind, placebo-controlled, crossover trial J Clin Endocrinol Metab 76 1217-1223

[8] Hirose R(1996)Gonadotropin releasing hormone (GnRH) and GnRH receptor gene expression in human myometrial and leiomyomta and the direct action of GnRH analogs on myometrial smooth muscle cells interaction with ovarian steroids in vitro J Clin Endocrinol Metab 81 3215-3221

[9] Ichigo S(1999)Matrix metalloproteinases and tissue inhibitor of MMPs (TIMPs): Expression in human myometrial smooth muscle cell and regulation by transforming growth factor β1 Mol Hum Reprod 5 950-954

[10] Sakaguchi H(1999)Regulation of transforming growth factor-β1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells J Clin Endocrinol Metab 84 4138-4143